Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
5.61
+0.39 (7.47%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Larimar Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 609 | 247 | 200 | 179 | 191 | 329 | |
| Market Cap Growth | 191.97% | 23.61% | 11.79% | -6.49% | -41.88% | - | |
| Enterprise Value | 420 | 49 | 110 | 60 | 119 | 233 | |
| Last Close Price | 5.22 | 3.87 | 4.55 | 4.13 | 10.79 | 21.41 | |
| PB Ratio | 3.21 | 1.44 | 2.44 | 1.61 | 2.97 | 3.67 | |
| P/TBV Ratio | 4.25 | 1.44 | 2.44 | 1.61 | 2.97 | 3.67 | |
| Debt / Equity Ratio | 0.03 | 0.03 | 0.07 | 0.05 | 0.09 | 0.07 | |
| Net Debt / Equity Ratio | -1.23 | -1.04 | -0.99 | -1.02 | -0.99 | -0.96 | |
| Net Debt / EBITDA Ratio | 1.23 | 1.97 | 1.96 | 3.12 | 1.28 | 2.02 | |
| Net Debt / FCF Ratio | 1.77 | 2.50 | 2.42 | 4.09 | 1.51 | 2.04 | |
| Quick Ratio | 3.91 | 7.58 | 9.16 | 11.06 | 7.95 | 10.31 | |
| Current Ratio | 4.06 | 8.02 | 9.49 | 11.28 | 8.16 | 10.89 | |
| Return on Equity (ROE) | -78.24% | -63.59% | -38.36% | -40.33% | -65.72% | -95.47% | |
| Return on Assets (ROA) | -42.99% | -38.36% | -23.48% | -22.26% | -34.40% | -48.69% | |
| Return on Capital Employed (ROCE) | -98.30% | -51.70% | -48.30% | -31.60% | -72.30% | -44.70% | |
| Earnings Yield | -22.34% | -32.64% | -18.50% | -19.78% | -26.50% | -12.92% | |
| FCF Yield | -16.38% | -28.86% | -16.83% | -15.48% | -22.21% | -12.85% | |
| Buyback Yield / Dilution | -20.08% | -39.53% | -70.42% | -50.09% | -44.44% | -95.09% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.